Mycophenolate mofetil for lupus related myelopathy

Mycophenolate mofetil: a magic bullet for lupus?

Treatment of lupus nephritis by mycophenolate mofetil.

BACKGROUND/AIMS Mycophenolate mofetil (MMF) has been increasingly used for the treatment of lupus nephritis (LN). The aim of this study was to examine the efficacy and safety of MMF used with low doses of corticosteroids as maintenance therapy in patients with LN. METHODS The study covered 35 patients, most of them with proliferative types of LN (5 WHO class III, 26 class IV), while 1 had cla...

Mycophenolate mofetil in neuropsychiatric systemic lupus erythematosus.

Neuropsychiatric abnormalities frequently occur in patients with systemic lupus erythematosus, affecting as many as 14-75% of people with this disease. High-dose steroid with or without anticoagulation is the mainstay of treatment in neuropsychiatric systemic lupus erythematosus (NPSLE). Use of mycophenolate as a steroid sparing drug may be a potential alternative agent in the therapy of NPLE, ...

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.

Recent studies have suggested that mycophenolate mofetil (MMF) may offer advantages over intravenous cyclophosphamide (IVC) for the treatment of lupus nephritis, but these therapies have not been compared in an international randomized, controlled trial. Here, we report the comparison of MMF and IVC as induction treatment for active lupus nephritis in a multinational, two-phase (induction and m...

Fetal malformations associated with mycophenolate mofetil for lupus nephritis.

Sir, Mycophenolate mofetil (MMF) has become a major therapeutic option as an induction and maintenance therapy for lupus nephritis [1,2]. Many patients with lupus are women of child-bearing age, so the issue of teratogenicity associated with MMF is important. MMF has been classified as category C by the American Food and Drug Administration. In other words, animal reproductive studies have show...